Editor in Chief Dr. Sue Yom co-hosts with Dr. Nicholas Zaorsky, an Associate Editor at the Journal and Associate Professor in the Department of Radiation Oncology at Case Western University Hospitals. We discuss three articles that are publishing rapid online for this meeting including Bladder Adjuvant RadioTherapy (BART): Acute and Late Toxicity from a Phase III Multicenter Randomized Controlled Trial, with the Principal Investigator Dr. Vedang Murthy, Professor in the Department of Radiation Oncology at Tata Memorial Centre in Mumbai, and its accompanying editorial, Adjuvant Radiation Therapy for Locally Advanced Bladder Cancer: A Safe and Promising  Emerging Treatment Option, with first author Dr. Brian Baumann, Radiation Oncologist at Springfield Clinic in Illinois. Relevant to this discussion is a paper appearing in this month's issue, The Value and Safety of Adjuvant Radiation Therapy After Radical Cystectomy in Locally Advanced Urothelial Bladder Cancer: A Controlled Randomized Study and its accompanying editorial, Is It Time to Reconsider the Place of Adjuvant Radiation Therapy After Radical Cystectomy? Finally, our third rapid online paper is Setting the Stage: Feasibility and Baseline Characteristics in the Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL) Trial Comparing Proton Therapy vs. IMRT for Localized Prostate Cancer, with Principal Investigator Dr. Jason Efstathiou, Professor of Radiation Oncology at Harvard Medical School, Massachusetts General Hospital.